Ambrx Employee Directory
Biotechnology ResearchCalifornia, United States51-200 Employees
Ambrx is a clinical-stage biotechnology company focused on discovering and developing next-generation antibody-drug conjugates and other engineered therapies aimed at modulating the immune system in cancer. The company pursues a portfolio of clinical and preclinical programs designed to optimize efficacy and safety across multiple cancer indications, underpinned by its expanded genetic code technology platform. Notable programs include ARX517, a PSMA-targeting antibody-drug conjugate, and ARX788, an ADC targeting HER2. Headquartered in La Jolla, California, Ambrx traces its origins to The Scripps Research Institute, from which it spun out in 2003. It operates as a mid-sized biotechnology company focused on oncology, developing ADCs and other protein-engineering approaches across its pipeline. Its customers and partners are pharmaceutical developers and research organizations seeking innovative therapies to treat cancer.